1. Home
  2. PAPL vs ENSC Comparison

PAPL vs ENSC Comparison

Compare PAPL & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAPL
  • ENSC
  • Stock Information
  • Founded
  • PAPL 2015
  • ENSC 2003
  • Country
  • PAPL Canada
  • ENSC United States
  • Employees
  • PAPL N/A
  • ENSC N/A
  • Industry
  • PAPL Finance: Consumer Services
  • ENSC Biotechnology: Pharmaceutical Preparations
  • Sector
  • PAPL Finance
  • ENSC Health Care
  • Exchange
  • PAPL Nasdaq
  • ENSC Nasdaq
  • Market Cap
  • PAPL 2.5M
  • ENSC 2.9M
  • IPO Year
  • PAPL 2023
  • ENSC N/A
  • Fundamental
  • Price
  • PAPL $0.29
  • ENSC $1.76
  • Analyst Decision
  • PAPL Strong Buy
  • ENSC
  • Analyst Count
  • PAPL 2
  • ENSC 0
  • Target Price
  • PAPL $5.25
  • ENSC N/A
  • AVG Volume (30 Days)
  • PAPL 54.5K
  • ENSC 178.9K
  • Earning Date
  • PAPL 04-14-2025
  • ENSC 05-12-2025
  • Dividend Yield
  • PAPL N/A
  • ENSC N/A
  • EPS Growth
  • PAPL N/A
  • ENSC N/A
  • EPS
  • PAPL N/A
  • ENSC N/A
  • Revenue
  • PAPL $2,848,365.00
  • ENSC $5,210,031.00
  • Revenue This Year
  • PAPL $22.95
  • ENSC N/A
  • Revenue Next Year
  • PAPL $29.98
  • ENSC N/A
  • P/E Ratio
  • PAPL N/A
  • ENSC N/A
  • Revenue Growth
  • PAPL 13.01
  • ENSC 133.58
  • 52 Week Low
  • PAPL $0.18
  • ENSC $1.70
  • 52 Week High
  • PAPL $2.14
  • ENSC $14.67
  • Technical
  • Relative Strength Index (RSI)
  • PAPL 43.64
  • ENSC 26.05
  • Support Level
  • PAPL $0.25
  • ENSC $1.70
  • Resistance Level
  • PAPL $0.31
  • ENSC $2.39
  • Average True Range (ATR)
  • PAPL 0.03
  • ENSC 0.33
  • MACD
  • PAPL 0.00
  • ENSC 0.05
  • Stochastic Oscillator
  • PAPL 52.78
  • ENSC 4.18

About PAPL Pineapple Financial Inc.

Pineapple Financial Inc is a Canada-based mortgage technology and brokerage company that provides mortgage brokerage services and technology solutions to Canadian mortgage agents, brokers, sub-brokers, brokerages, and consumers. Through its data-driven systems together with cloud-based tools, it offers advantages in the Canadian mortgage industry relative to alternative mortgage broker arrangements and also provides back office services.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: